These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 38446012)

  • 1. Evaluating the role of wound-healing genes in conjunction with stool routine and serum tumor markers for colorectal cancer diagnosis and prognostic implications.
    Yu K; Fang X
    Int Wound J; 2024 Mar; 21(3):e14768. PubMed ID: 38446012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic value of CEA, beta HCG, AFP, CA125, CA19-9 and C-erb B-2, beta HCG immunohistochemistry in advanced colorectal cancer.
    Webb A; Scott-Mackie P; Cunningham D; Norman A; Andreyev J; O'Brien M; Bensted J
    Ann Oncol; 1995 Jul; 6(6):581-7. PubMed ID: 8573538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of serum human tumor protein P53 in colorectal cancer combined diagnosis and postoperative monitoring].
    Fan P; Zhang Y; Deng F; Chen SH; Li M; Zhang Q
    Zhonghua Yi Xue Za Zhi; 2017 Sep; 97(34):2670-2673. PubMed ID: 28910954
    [No Abstract]   [Full Text] [Related]  

  • 4. Serum CA724 has no diagnostic value for gastrointestinal tumors.
    Cao H; Zhu L; Li L; Wang W; Niu X
    Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer.
    Gao Y; Wang J; Zhou Y; Sheng S; Qian SY; Huo X
    Sci Rep; 2018 Feb; 8(1):2732. PubMed ID: 29426902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical Value of Combined Determination of Serum B7-H4 with Carcinoembryonic Antigen, Osteopontin, or Tissue Polypeptide-Specific Antigen for the Diagnosis of Colorectal Cancer.
    Wang P; Li C; Zhang F; Ma X; Gai X
    Dis Markers; 2018; 2018():4310790. PubMed ID: 30363700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical Value of Serum CEA, CA24-2 and CA19-9 in Patients with Colorectal Cancer.
    Rao H; Wu H; Huang Q; Yu Z; Zhong Z
    Clin Lab; 2021 Apr; 67(4):. PubMed ID: 33865243
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between Stool DNA-based SDC2 Methylation Tests Combined with Tumor Markers with Pathological Features in Colorectal Cancer.
    Cheng Z; Wang Y; Wei W; Liu Y; Zhou Z
    Clin Lab; 2023 Jul; 69(7):. PubMed ID: 37436377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF)--a valuable serum tumour marker in patients with colorectal cancer?
    Broll R; Erdmann H; Duchrow M; Oevermann E; Schwandner O; Markert U; Bruch HP; Windhövel U
    Eur J Surg Oncol; 2001 Feb; 27(1):37-42. PubMed ID: 11237490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serum Metadherin mRNA expression in the diagnosis and prediction of survival in patients with colorectal cancer.
    Abdel Ghafar MT; Gharib F; Abdel-Salam S; Elkhouly RA; Elshora A; Shalaby KH; El-Guindy D; El-Rashidy MA; Soliman NA; Abu-Elenin MM; Allam AA
    Mol Biol Rep; 2020 Apr; 47(4):2509-2519. PubMed ID: 32088817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical value of combining serum tumor marker detection with fecal occult blood testing in diagnosing colorectal cancer.
    Zhou H; Wang XC; Yuan BB; Lu BB
    J Physiol Pharmacol; 2022 Jun; 73(3):. PubMed ID: 36515627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Clinical Diagnostic and Prognostic Value of Preoperative Serum Carcinoembryonic Antigen, CA19-9, and CA24-2 for Colorectal Cancer.
    Hou S; Jing J; Wang Y; Du L; Tian B; Xu X; Sun T; Shi Y
    Altern Ther Health Med; 2023 Sep; 29(6):192-197. PubMed ID: 37295009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined detection tumor markers for diagnosis and prognosis of gallbladder cancer.
    Wang YF; Feng FL; Zhao XH; Ye ZX; Zeng HP; Li Z; Jiang XQ; Peng ZH
    World J Gastroenterol; 2014 Apr; 20(14):4085-92. PubMed ID: 24744600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
    Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoembryonic antigen, carbohydrate antigen 199 and carbohydrate antigen 724 in gastric cancer and their relationship with clinical prognosis.
    Wang R; Zuo CL; Zhang R; Zhu LM
    World J Gastrointest Oncol; 2023 Aug; 15(8):1475-1485. PubMed ID: 37663935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Carcinoembryonic Antigen (CEA), AFP, CA19-9 and CA125 for Patients with Colorectal Cancer with Peritoneal Carcinomatosis Treated by Cytoreductive Surgery and Intraperitoneal Chemotherapy.
    Huo YR; Huang Y; Liauw W; Zhao J; Morris DL
    Anticancer Res; 2016 Mar; 36(3):1041-9. PubMed ID: 26976996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The evaluation of diagnostic value of the tumor markers: CCSA-2 and CEA in colorectal cancer.
    Knychalski B; Lukieńczuk T
    Pol Przegl Chir; 2012 Feb; 84(2):86-92. PubMed ID: 22487741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CEA, CA 242, CA 19-9, CA 72-4 and hCGbeta in the diagnosis of recurrent colorectal cancer.
    Carpelan-Holmström M; Louhimo J; Stenman UH; Alfthan H; Järvinen H; Haglund C
    Tumour Biol; 2004; 25(5-6):228-34. PubMed ID: 15627885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical validity of tissue carcinoembryonic antigen expression as ancillary to serum carcinoembryonic antigen concentration in patients curatively resected for colorectal cancer.
    Park JW; Chang HJ; Kim BC; Yeo HY; Kim DY
    Colorectal Dis; 2013 Sep; 15(9):e503-11. PubMed ID: 23711333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor marker utility and prognostic relevance of cathepsin B, cathepsin L, urokinase-type plasminogen activator, plasminogen activator inhibitor type-1, CEA and CA 19-9 in colorectal cancer.
    Herszényi L; Farinati F; Cardin R; István G; Molnár LD; Hritz I; De Paoli M; Plebani M; Tulassay Z
    BMC Cancer; 2008 Jul; 8():194. PubMed ID: 18616803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.